Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 3/20 | 0.39 |
| ▸ | ELANE | P08246 | 2/20 | 0.32 |
| ▸ | REN | P00797 | 1/20 | 0.31 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.31 |
| ▸ | CCR5 | P51681 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13685083 | 0.96 | BACE1 (0.42) | BACE1ELANERENSCN9AATM | |
| SCHEMBL13685009 | 0.91 | BACE1 (0.34) | BACE1ELANECCR5 | |
| SCHEMBL13685169 | 0.91 | BACE1 (0.34) | BACE1ELANECCR5 | |
| SCHEMBL16349773 | 0.88 | BACE1 (0.36) | BACE1ELANERENATMMEN1 | |
| SCHEMBL13685020 | 0.88 | BACE1 (0.36) | BACE1ELANERENATMMEN1 | |
| SCHEMBL8035823 | 0.88 | BACE1 (0.36) | BACE1ELANERENATMMEN1 | |
| SCHEMBL16349593 | 0.88 | BACE1 (0.36) | BACE1ELANERENATMMEN1 | |
| SCHEMBL8290555 | 0.88 | BACE1 (0.36) | BACE1ELANERENATMMEN1 | |
| SCHEMBL13685129 | 0.87 | BACE1 (0.36) | BACE1ELANERENSCN9A | |
| SCHEMBL13685011 | 0.87 | BACE1 (0.36) | BACE1ELANERENSCN9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7592419-B2 | Macrocyclic inhibitors of hepatitis C virus NS3-serine protease | SCHERING CORPORATION (US) | 2009-09-22 | — | — | US | disclosed |
| US-7592419-B2 | Macrocyclic inhibitors of hepatitis C virus NS3-serine protease | SCHERING CORPORATION (US) | 2009-09-22 | — | — | US | disclosed |